Action brought on 24 August 2023 — Boehringer Ingelheim Pharma v EUIPO — Glenmark Pharmaceuticals Europe (Shape of inhaler)

(Case T-524/23)

(C/2023/72)

Language in which the application was lodged: English

Parties

Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG (Ingelheim, Germany) (represented by: I. Fowler and C. Stöber, lawyers)

Defendant: European Union Intellectual Property Office

Other party to the proceedings before the Board of Appeal: Glenmark Pharmaceuticals Europe Ltd (Watford, United Kingdom)

Details of the proceedings before EUIPO

Proprietor of the trade mark at issue: Applicant before the General Court

Trade mark at issue: European Union tridimensional mark (Shape of inhaler) –European Union trade mark No 1 243 484

Procedure before EUIPO: Cancellation proceedings

Contested decision: Decision of the Forth Board of Appeal of EUIPO of 13 June 2023 in Case R 1558/2021-4

Form of order sought

The applicant claims that the Court should:

—	annul the contested decision;

—	order that the costs of the proceedings be borne by the defendant, and in the event that the other party before the Board of Appeal joins the proceedings, by the intervener.

Plea(s) in law

—	Infringement of Article 59(1)(a) of Regulation (EU) 2017/1001 of the European Parliament and of the Council in conjunction with Article 7(1)(e)(ii) of Council Regulation (EC) No 40/94;

—	Infringement of Article 94 of Regulation (EU) 2017/1001 of the European Parliament and of the Council.